Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Pfizer, Obesity Drug

Digest more
 · 1d · on MSN
Pfizer Wins Obesity Drug Battle, With Assist by Trump’s FTC
Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he learned he’d finally claimed his prize.

Continue reading

 · 1d · on MSN
Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.
 · 7h
Metsera: Why Pfizer And Novo Nordisk Fought Hard Over This Obesity Drug Developer
STAT
21h

The $10 billion question: Will Pfizer hit it big with Metsera, or have regrets?

At a price of up to $10 billion, Pfizer has claimed victory in its bidding war against Novo Nordisk to acquire Metsera. It's ...
Fierce Biotech
3h

With Summit leading the pack in PD-1xVEGF bispecifics, Pfizer lays out its own plan to replace Keytruda

As the race to develop oncology bispecifics heats up, Pfizer has offered a first look at its strategy to dethrone Keytruda and establish its ...
9hon MSN

Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
7d

Transcript: Pfizer plays hardball in weight-loss drug fight

Marc Filippino Good morning from the Financial Times. Today is Tuesday, November 4th, and this is your FT News Briefing.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms